Stock Traders Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) saw unusually large options trading on Wednesday. Traders purchased 1,002 put options on the stock. This represents an increase of 1,791% compared to the average volume of 53 put options.

Insiders Place Their Bets

In related news, insider Carl Hull acquired 175,000 shares of Maravai LifeSciences stock in a transaction that occurred on Monday, November 11th. The stock was acquired at an average price of $5.64 per share, for a total transaction of $987,000.00. Following the transaction, the insider now directly owns 175,000 shares of the company’s stock, valued at $987,000. This trade represents a ? increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.63% of the stock is owned by company insiders.

Institutional Trading of Maravai LifeSciences

Several large investors have recently made changes to their positions in the company. Point72 Asia Singapore Pte. Ltd. bought a new position in Maravai LifeSciences in the second quarter valued at about $32,000. Venturi Wealth Management LLC bought a new stake in shares of Maravai LifeSciences during the third quarter worth $47,000. Custom Index Systems LLC acquired a new position in shares of Maravai LifeSciences during the third quarter worth $97,000. Y Intercept Hong Kong Ltd bought a new stake in Maravai LifeSciences during the 3rd quarter worth $105,000. Finally, Headlands Technologies LLC raised its position in Maravai LifeSciences by 205.9% in the second quarter. Headlands Technologies LLC now owns 14,935 shares of the company’s stock valued at $107,000 after purchasing an additional 10,053 shares during the last quarter. Institutional investors and hedge funds own 50.25% of the company’s stock.

Maravai LifeSciences Trading Up 1.3 %

Shares of MRVI stock opened at $6.13 on Thursday. The company has a market capitalization of $1.55 billion, a PE ratio of -3.74 and a beta of -0.07. The company has a quick ratio of 9.94, a current ratio of 10.74 and a debt-to-equity ratio of 0.89. Maravai LifeSciences has a 12-month low of $4.28 and a 12-month high of $11.56. The firm has a 50 day moving average price of $5.73 and a two-hundred day moving average price of $7.43.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. William Blair reiterated a “market perform” rating on shares of Maravai LifeSciences in a research report on Friday, November 8th. Royal Bank of Canada decreased their target price on shares of Maravai LifeSciences from $17.00 to $13.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Guggenheim started coverage on Maravai LifeSciences in a research note on Thursday, December 19th. They issued a “neutral” rating on the stock. Wolfe Research assumed coverage on Maravai LifeSciences in a report on Thursday, November 14th. They set a “peer perform” rating for the company. Finally, The Goldman Sachs Group lowered shares of Maravai LifeSciences from a “neutral” rating to a “sell” rating and cut their price objective for the company from $7.00 to $4.25 in a research report on Thursday, December 5th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $10.28.

About Maravai LifeSciences

Maravai LifeSciences Holdings, Inc, a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company’s products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species.